نتایج جستجو برای: chromosorb 102
تعداد نتایج: 24460 فیلتر نتایج به سال:
In metastatic colorectal cancer (mCRC) the choice of treatment should take into account characteristics tumor and patient, as well its efficacy tolerability. The RECOURSE study demonstrated that presence low burden indolent disease has an impact on progression-free (PFS) overall (OS) survival patients treated with trifluridine/tipiracil (TAS-102). Retrospective included mCRC undergoing TAS-102 ...
Abstract Study question Which add-ons are effective and safe to use in the ART clinic? Summary answer More than thirty recommendations were formulated on of diagnosis diagnostic tests, laboratory tests intervention, clinical management. What is known already Treatment not essential for treatment but optional additional treatments that sometimes offered top routine fertility treatment. There a w...
Abstract High pharmaceutical pricing practices in Europe have been increasingly on the radar of European Union, academia and civil society as a risk to Member State health budgets. It is therefore hardly surprising that, recent years, competition authorities resuscitated excessive prohibition contained Article 102(a) TFEU. Focusing this phenomenon, piece highlights diverse ways which United Bra...
McCafferty, Donna-Marie, Elaine Sihota, Marcelo Muscara, John L. Wallace, Keith A. Sharkey, and Paul Kubes. Spontaneously developing chronic colitis in IL-10/ iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 279: G90–G99, 2000.—Mice deficient in both inducible nitric oxide synthase (iNOS) and interleukin (IL)-10 (iNOS2/2/IL-102/2) were created to examine the role of iNOS in s...
BACKGROUND A herbal preparation, known as RMIT Chinese Medicine 102 (RCM-102) consisting of eight herbs which demonstrates inhibition of the release of key inflammatory mediators associated with seasonal allergic rhinitis (SAR) was used. This study evaluated the efficacy and safety of RCM-102 for SAR. OBJECTIVE This study evaluated the efficacy and safety of RCM-102 for SAR. METHODS This ra...
BACKGROUND Early clinical trials conducted primarily in Japan have shown that TAS-102, an oral agent that combines trifluridine and tipiracil hydrochloride, was effective in the treatment of refractory colorectal cancer. We conducted a phase 3 trial to further assess the efficacy and safety of TAS-102 in a global population of such patients. METHODS In this double-blind study, we randomly ass...
BACKGROUND TAS-102 improves overall survival (OS) in patients with metastatic colorectal cancer (mCRC) refractory to standard treatments. However, predictive biomarkers of efficacy are currently lacking. PATIENTS AND METHODS We treated a cohort of 43 chemorefractory mCRC patients treated with TAS-102, in a single institution expanded access, compassionate use programme. We stratified patients...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید